Stay updated with breaking news from Daniel Pichl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a report released on Thursday, RTT News reports. They presently have a $75.00 price objective on the stock, up from their previous price objective of $70.00. Wedbush’s price target indicates a potential upside of 66.26% from […]
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 759,786 shares traded hands during mid-day trading, a decline of 30% from the previous session’s volume of 1,085,049 shares.The stock last traded at $42.19 and had previously closed at $46.84. Analyst Ratings Changes A number of equities research analysts […]
SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) is set to release its earnings data before the market opens on Thursday, May 2nd. Analysts expect SpringWorks Therapeutics to post earnings of ($1.19) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. SpringWorks Therapeutics (NASDAQ:SWTX […]
Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have earned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) – Analysts at Wedbush raised their Q1 2024 EPS estimates for SpringWorks Therapeutics in a research report issued to clients and investors on Tuesday, February 27th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($1.27) per share for the quarter, up from their […]